Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Mar 6;82(7):1266–1270. doi: 10.1054/bjoc.1999.1089

Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families

A Osorio 1, A Barroso 1, B Martínez 1, A Cebrián 1, J M San Román 2, F Lobo 3, M Robledo 1, J Benítez 1
PMCID: PMC2374482  PMID: 10755399

Abstract

It is estimated that about 5–10% of breast cancer cases may be due to inherited predisposition. Until now, two main susceptibility genes have been identified: BRCA1 and BRCA2. The first linkage and mutational studies suggested that mutations in these two genes would account for the majority of high-risk breast cancer families, but recent studies show how the proportion of families due to BRCA1 or BRCA2 mutations strongly depends on the population and the types of family analyzed. It is now clear that, in the context of families with a modest cancer profile, which are the most commonly found in the clinical practice, the percentage of mutations found is much lower than that suggested by the first studies. In the present study, we analyze a group of 32 Spanish families, which contatined at least three cases of female breast cancer (at least one of them diagnosed before the age of 50 years), for the presence of mutations in the BRCA genes. The total proportion of mutations was low (25%), although the percentage of mutations in the BRCA1 and BRCA2 genes was higher, considering the breast and ovarian cancer families and the male breast cancer families respectively. Our results are in agreement with the idea that a great proportion of moderate-risk cancer families could be due to low penetrance susceptibility genes distinct from BRCA1 or BRCA2. © 2000 Cancer Research Campaign

Keywords: BRCA1, BRCA2, mutation, ovarian cancer, male breast cancer

Full Text

The Full Text of this article is available as a PDF (57.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel K. J., Xu J., Yin G. Y., Lyons R. H., Meisler M. H., Weber B. L. Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains. Hum Mol Genet. 1995 Dec;4(12):2265–2273. doi: 10.1093/hmg/4.12.2265. [DOI] [PubMed] [Google Scholar]
  2. Blackwood M. A., Weber B. L. BRCA1 and BRCA2: from molecular genetics to clinical medicine. J Clin Oncol. 1998 May;16(5):1969–1977. doi: 10.1200/JCO.1998.16.5.1969. [DOI] [PubMed] [Google Scholar]
  3. Couch F. J., DeShano M. L., Blackwood M. A., Calzone K., Stopfer J., Campeau L., Ganguly A., Rebbeck T., Weber B. L. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med. 1997 May 15;336(20):1409–1415. doi: 10.1056/NEJM199705153362002. [DOI] [PubMed] [Google Scholar]
  4. Díez O., Doménech M., Alonso M. C., Brunet J., Sanz J., Cortés J., del Río E., Baiget M. Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population. Hum Genet. 1998 Dec;103(6):707–708. doi: 10.1007/s004390050895. [DOI] [PubMed] [Google Scholar]
  5. Díez O., Osorio A., Robledo M., Barroso A., Domènech M., Cortés J., Albertos J., Sanz J., Brunet J., SanRomán J. M. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients. Br J Cancer. 1999 Mar;79(7-8):1302–1303. doi: 10.1038/sj.bjc.6690208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Easton D. F., Bishop D. T., Ford D., Crockford G. P. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1993 Apr;52(4):678–701. [PMC free article] [PubMed] [Google Scholar]
  7. Ford D., Easton D. F., Stratton M., Narod S., Goldgar D., Devilee P., Bishop D. T., Weber B., Lenoir G., Chang-Claude J. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998 Mar;62(3):676–689. doi: 10.1086/301749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Garcia-Patiño E., Gomendio B., Provencio M., Silva J. M., Garcia J. M., España P., Bonilla F. Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations. J Clin Oncol. 1998 Jan;16(1):115–120. doi: 10.1200/JCO.1998.16.1.115. [DOI] [PubMed] [Google Scholar]
  9. Hogervorst F. B., Cornelis R. S., Bout M., van Vliet M., Oosterwijk J. C., Olmer R., Bakker B., Klijn J. G., Vasen H. F., Meijers-Heijboer H. Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet. 1995 Jun;10(2):208–212. doi: 10.1038/ng0695-208. [DOI] [PubMed] [Google Scholar]
  10. Lynch H. T., Fain P. R., Golgar D., Albano W. A., Mailliard J. A., McKenna P. Familial breast cancer and its recognition in an oncology clinic. Cancer. 1981 Jun 1;47(11):2730–2739. doi: 10.1002/1097-0142(19810601)47:11<2730::aid-cncr2820471132>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  11. Malone K. E., Daling J. R., Thompson J. D., O'Brien C. A., Francisco L. V., Ostrander E. A. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA. 1998 Mar 25;279(12):922–929. doi: 10.1001/jama.279.12.922. [DOI] [PubMed] [Google Scholar]
  12. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. doi: 10.1126/science.7545954. [DOI] [PubMed] [Google Scholar]
  13. Neuhausen S. L., Godwin A. K., Gershoni-Baruch R., Schubert E., Garber J., Stoppa-Lyonnet D., Olah E., Csokay B., Serova O., Lalloo F. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet. 1998 Jun;62(6):1381–1388. doi: 10.1086/301885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Osorio A., Robledo M., Albertos J., Díez O., Alonso C., Baiget M., Benítez J. Molecular analysis of the six most recurrent mutations in the BRCA1 gene in 87 Spanish breast/ovarian cancer families. Cancer Lett. 1998 Jan 30;123(2):153–158. doi: 10.1016/s0304-3835(97)00416-3. [DOI] [PubMed] [Google Scholar]
  15. Schubert E. L., Lee M. K., Mefford H. C., Argonza R. H., Morrow J. E., Hull J., Dann J. L., King M. C. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet. 1997 May;60(5):1031–1040. [PMC free article] [PubMed] [Google Scholar]
  16. Serova O. M., Mazoyer S., Puget N., Dubois V., Tonin P., Shugart Y. Y., Goldgar D., Narod S. A., Lynch H. T., Lenoir G. M. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet. 1997 Mar;60(3):486–495. [PMC free article] [PubMed] [Google Scholar]
  17. Simard J., Tonin P., Durocher F., Morgan K., Rommens J., Gingras S., Samson C., Leblanc J. F., Bélanger C., Dion F. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet. 1994 Dec;8(4):392–398. doi: 10.1038/ng1294-392. [DOI] [PubMed] [Google Scholar]
  18. Stratton M. R., Ford D., Neuhasen S., Seal S., Wooster R., Friedman L. S., King M. C., Egilsson V., Devilee P., McManus R. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet. 1994 May;7(1):103–107. doi: 10.1038/ng0594-103. [DOI] [PubMed] [Google Scholar]
  19. Szabo C. I., King M. C. Population genetics of BRCA1 and BRCA2. Am J Hum Genet. 1997 May;60(5):1013–1020. [PMC free article] [PubMed] [Google Scholar]
  20. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995 Dec 21;378(6559):789–792. doi: 10.1038/378789a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES